Antiphospholipid Syndrome Current Research Highlights and Clinical I
This new edition is a comprehensive and updated resource on antiphospholipid syndrome (APS), which is an autoimmune disorder. In APS, the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodie
- PDF / 6,345,194 Bytes
- 371 Pages / 439.42 x 683.15 pts Page_size
- 67 Downloads / 180 Views
Antiphospholipid Syndrome Current Research Highlights and Clinical Insights
123
Antiphospholipid Syndrome
Doruk Erkan • Michael D. Lockshin Editors
Antiphospholipid Syndrome Current Research Highlights and Clinical Insights
Editors Doruk Erkan, MD, MPH Associate Physician-Scientist The Barbara Volcker Center for Women and Rheumatic Diseases Associate Attending Physician Hospital for Special Surgery Associate Professor of Medicine Weill Cornell Medicine New York, NY, USA
Michael D. Lockshin, MD Director The Barbara Volcker Center for Women and Rheumatic Diseases Attending Physician Hospital for Special Surgery Professor of Medicine and Obstetrics-Gynecology Weill Cornell Medicine New York, NY, USA
ISBN 978-3-319-55440-2 ISBN 978-3-319-55442-6 (eBook) DOI 10.1007/978-3-319-55442-6 Library of Congress Control Number: 2017935363 © Springer International Publishing AG 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
To: ARIN, AYDIN, & RACHEL (DE) AMANDA & JANE (MDL)
Preface
“Advancing the Field Together” – The Journey that started in planning for the 15th International Congress on Antiphospholipid Antibodies continues with a State-of- the-Art Antiphospholipid Syndrome book The International Congress on Antiphospholipid Antibodies (aPL) takes place every three years; its purpose is to discuss aPL and antiphospholipid syndrome (APS) research and clinical care. The Congress is a venue in which scientists and clinicians, from multiple disciplines, present and review the most recent innovative and important research to improve understanding of the syndrome, prioritize research questions, and set a roadmap for future research. The
Data Loading...
